Application Nr Approved Date Route Status External Links
ANDA205571 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Epilepsy Carbamazepine Extended-Release Tablets Are Indicated For Use As An Anticonvulsant Drug. Evidence Supporting Efficacy Of Carbamazepine Extended-Release Tablets As An Anticonvulsant Was Derived From Active Drug-Controlled Studies That Enrolled Patients With The Following Seizure Types: Partial Seizures With Complex Symptomatology (Psychomotor, Temporal Lobe). Patients With These Seizures Appear To Show Greater Improvement Than Those With Other Types. Generalized Tonic-Clonic Seizures (Grand Mal). Mixed Seizure Patterns Which Include The Above, Or Other Partial Or Generalized Seizures. Absence Seizures (Petit Mal) Do Not Appear To Be Controlled By Carbamazepine Extended-Release Tablets (See Precautions, General ). Trigeminal Neuralgia Carbamazepine Extended-Release Tablets Are Indicated In The Treatment Of The Pain Associated With True Trigeminal Neuralgia. Beneficial Results Have Also Been Reported In Glossopharyngeal Neuralgia. This Drug Is Not A Simple Analgesic And Should Not Be Used For The Relief Of Trivial Aches Or Pains.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Carbamazepine CARBAMAZEPINE ZINC4785

Comments